Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of remifentanil in pediatric preterm infants
KCT0000288Phase 2Recruiting
- Sponsor
- Ministry of Food and Drug Safety
- Start
- Dec 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of remifentanil in preterm birth, sponsored by Ministry of Food and Drug Safety. Started Dec 2011; status: recruiting.
02
Drugs
remifentanil
03
Conditions
preterm birth
Beyond the preview
Go deeper on KCT0000288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000288.